Aspen Pharmacare Building China Presence For Its Generic Drug Portfolio

Published: Jul 26, 2016

Aspen Pharmacare, the South African generic drugmaker, plans to build its presence in China by adding 500 sales representatives in the near future. The company believes its products have the quality equivalent to big pharma drugs at a lower price -- the ideal formula for China, it says. In addition, Aspen is looking for "opportunities" to expand its offerings in China and elsewhere, according to its CEO, Stephen Saad, who was speaking to Bloomberg.

Back to news